{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:17:12Z","timestamp":1792682232931,"version":"4.5.0"},"reference-count":105,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Little is known about patterns (forms, frequency, and reasons) and factors associated with cannabis use in older veterans (aged \u226565 years).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine factors associated with past 30-day cannabis use and cannabis use disorder (CUD) in older veterans.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this cross-sectional study, community-dwelling adults aged 65 to 84 years who used Veterans Health Administration care were interviewed between February 5, 2020, and August 29, 2023.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Sociodemographic, behavioral, and health-related characteristics.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Past 30-day cannabis use (smoking, vaping, dabbing, or edibles) and any CUD (\u22652 criteria based on\n Diagnostic and Statistical Manual of Mental Disorders<\/jats:italic>\n [Fifth Edition]) were assessed using weighted multivariable logistic regressions.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of the 4503 participants (weighted mean age, 73.3 years [95% CI, 73.0-73.5 years]; 85.4% [95% CI, 83.6%-87.2%] men), 58.2% (95% CI, 55.3%-61.0%) had ever used cannabis, 28.9% (95% CI, 26.0%-31.8%) of whom reported using cannabis for medical reasons, most commonly for pain (56.4%; 95% CI, 50.9%-61.9%), mood or mental health (18.4%; 95% CI, 14.7%-22.1%), and sleep (16.0%; 95% CI, 11.9%-20.0%). More than 1 in 10 reported past 30-day cannabis use (10.3%; 95% CI, 8.9%-11.7%), with 52.4% (95% CI, 45.4%-59.4%) of these using cannabis for 20 days or more; smoking (72.4%; 95% CI, 65.4%-79.3%) and edibles (36.9%; 95% CI, 29.8%-43.9%) were the most common forms of use. Characteristics associated with past 30-day use included younger age (65-75 years), economic hardship, tobacco and illicit drug use, and residing in a state with recreationally legal cannabis. Among those with past 30-day cannabis use, 36.3% (95% CI, 30.1%-42.6%) screened positive for CUD, with higher odds among younger respondents, those reporting anxiety, those with 1 or more deficits in activities of daily living, those with illicit drug use, those with frequent cannabis use, and those using cannabis recreationally. Past 30-day inhaled cannabis use, compared with edibles only, was associated with increased odds of any CUD (adjusted odds ratio, 3.56; 95% CI, 1.12-11.26).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of cannabis use in older veterans, use was common, and more than one-third who used in the past 30 days had any CUD. The prevalence of past 30-day cannabis use was close to tobacco use prevalence, and risk factors for cannabis use were similar to those observed in other populations. Frequent and inhaled cannabis use was associated with higher odds of any CUD. Routine health screening for cannabis use in Veterans Health Administration clinical settings is necessary to identify older adults with cannabis use.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.10173","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:00:56Z","timestamp":1747220456000},"page":"e2510173","source":"Crossref","is-referenced-by-count":37,"title":["Cannabis Use Among Older Adults"],"prefix":"10.1001","volume":"8","author":[{"given":"Vira","family":"Pravosud","sequence":"first","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"Northern California Institute for Research and Education, San Francisco"},{"name":"Center for Tobacco Control Research and Education, Cardiovascular Research Institute, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Lum","sequence":"additional","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"Northern California Institute for Research and Education, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Vali","sequence":"additional","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"Northern California Institute for Research and Education, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"School of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Hoggatt","sequence":"additional","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"School of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Byers","sequence":"additional","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"School of Medicine, University of California, San Francisco"},{"name":"Division of Geriatrics, San Francisco VA Health Care System, San Francisco, California"},{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Walter","sequence":"additional","affiliation":[{"name":"School of Medicine, University of California, San Francisco"},{"name":"Division of Geriatrics, San Francisco VA Health Care System, San Francisco, California"},{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hasin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauheed","family":"Zaman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco"},{"name":"Addiction Recovery and Treatments Services, San Francisco VA Health Care System, San Francisco VA Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomeh","family":"Keyhani","sequence":"additional","affiliation":[{"name":"Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California"},{"name":"School of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"6","key":"zoi250366r1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jamapsychiatry.2017.0724","article-title":"US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013.","volume":"74","author":"Hasin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"zoi250366r4","doi-asserted-by":"publisher","DOI":"10.1177\/2333721418781668","article-title":"Marijuana use among adults 50 years or older in the 21st century.","author":"Lloyd","year":"2018","journal-title":"Gerontol Geriatr Med"},{"issue":"3","key":"zoi250366r6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/add.13670","article-title":"Demographic trends among older cannabis users in the United States, 2006-13.","volume":"112","author":"Han","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"zoi250366r7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/JGP.0b013e318190b8ef","article-title":"The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health.","volume":"17","author":"Blazer","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"zoi250366r8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jamainternmed.2019.7517","article-title":"Trends in cannabis use among older adults in the United States, 2015-2018.","volume":"180","author":"Han","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"8","key":"zoi250366r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28691","article-title":"Perceptions of safety of daily cannabis vs tobacco smoking and secondhand smoke exposure, 2017-2021.","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi250366r11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/add.16016","article-title":"Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study.","volume":"118","author":"Zellers","year":"2023","journal-title":"Addiction"},{"issue":"9","key":"zoi250366r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.27002","article-title":"Racial and ethnic differences in cannabis use following legalization in US states with medical cannabis laws.","volume":"4","author":"Martins","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi250366r13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamapsychiatry.2019.3254","article-title":"Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016.","volume":"77","author":"Cerd\u00e1","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"zoi250366r14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhealeco.2015.03.007","article-title":"The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances.","volume":"42","author":"Wen","year":"2015","journal-title":"J Health Econ"},{"key":"zoi250366r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104618","article-title":"Cannabis legalization and changes in cannabis and tobacco\/nicotine use and co-use in a national cohort of U.S. adults during 2017-2021.","volume":"134","author":"Pravosud","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"4","key":"zoi250366r16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamapsychiatry.2023.0019","article-title":"State cannabis legalization and cannabis use disorder in the US Veterans Health Administration, 2005 to 2019.","volume":"80","author":"Hasin","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"zoi250366r17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.17634","article-title":"State cannabis legalization and trends in cannabis-related disorders in US older adults, 2017 to 2022.","volume":"7","author":"Perez-Vilar","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi250366r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103812","article-title":"Older adults experiences of using recreational cannabis for medicinal purposes following legalization.","volume":"108","author":"Baumbusch","year":"2022","journal-title":"Int J Drug Policy"},{"key":"zoi250366r19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.addbeh.2016.07.006","article-title":"Factors associated with having a medical marijuana card among veterans with recent substance use in VA outpatient treatment.","volume":"63","author":"Davis","year":"2016","journal-title":"Addict Behav"},{"issue":"6","key":"zoi250366r20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.clinthera.2023.04.003","article-title":"Self-reported medicinal cannabis use as an alternative to prescription and over-the-counter medication use among US military veterans.","volume":"45","author":"McNabb","year":"2023","journal-title":"Clin Ther"},{"issue":"9868","key":"zoi250366r22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people.","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"zoi250366r23","first-page":"7","article-title":"Surveillance for morbidity and mortality among older adults\u2013United States, 1995-1996.","volume":"48","author":"Desai","year":"1999","journal-title":"MMWR CDC Surveill Summ"},{"issue":"4","key":"zoi250366r24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37927","article-title":"Cannabis-induced acute encephalopathy in a 94-year-old woman due to family administration of cannabidiol (CBD) products: a case report.","volume":"15","author":"Moussa","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"zoi250366r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281826","article-title":"Impacts of medical and non-medical cannabis on the health of older adults: findings from a scoping review of the literature.","volume":"18","author":"Wolfe","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"zoi250366r26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: examination of the evidence.","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br J Psychiatry"},{"issue":"8574","key":"zoi250366r27","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia: a longitudinal study of Swedish conscripts.","volume":"2","author":"Andr\u00e9asson","year":"1987","journal-title":"Lancet"},{"issue":"7374","key":"zoi250366r28","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"zoi250366r29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fnins.2014.00361","article-title":"Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.","volume":"8","author":"Renard","year":"2014","journal-title":"Front Neurosci"},{"issue":"2","key":"zoi250366r30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7326\/M18-0522","article-title":"Marijuana use, respiratory symptoms, and pulmonary function.","volume":"169","author":"Ghasemiesfe","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi250366r31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11883-017-0663-0","article-title":"What is the current knowledge about the cardiovascular risk for users of cannabis-based products? a systematic review.","volume":"19","author":"Jouanjus","year":"2017","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"zoi250366r32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030178","article-title":"Association of cannabis use with cardiovascular outcomes among US adults.","volume":"13","author":"Jeffers","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"zoi250366r33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003858","article-title":"One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function.","volume":"5","author":"Wang","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi250366r34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.hrthm.2022.09.021","article-title":"Increased vulnerability to atrial and ventricular arrhythmias caused by different types of inhaled tobacco or marijuana products.","volume":"20","author":"Qiu","year":"2023","journal-title":"Heart Rhythm"},{"issue":"4","key":"zoi250366r35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/hearts5040030","article-title":"Adverse cardiovascular outcomes in young cannabis users: a nationwide analysis.","volume":"5","author":"Joseph Varughese","year":"2024","journal-title":"Hearts (Basel)"},{"issue":"1","key":"zoi250366r36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/jcm10010015","article-title":"Cannabis use, cannabis use disorder, and comorbid psychiatric illness: a narrative review.","volume":"10","author":"Hasin","year":"2020","journal-title":"J Clin Med"},{"key":"zoi250366r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109582","article-title":"Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: a systematic review and meta-analysis.","volume":"238","author":"Robinson","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi250366r38","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.4088\/JCP.14m09469","article-title":"Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"77","author":"Cougle","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"zoi250366r39","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/add.16519","article-title":"Changes in self-reported cannabis use in the United States from 1979 to 2022.","volume":"119","author":"Caulkins","year":"2024","journal-title":"Addiction"},{"issue":"7","key":"zoi250366r40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/ajad.12598","article-title":"Nonmedical versus medical marijuana use among three age groups of adults: associations with mental and physical health status.","volume":"26","author":"Choi","year":"2017","journal-title":"Am J Addict"},{"issue":"8","key":"zoi250366r41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28934","article-title":"Prevalence of cannabis use disorder and reasons for use among adults in a US state where recreational cannabis use is legal.","volume":"6","author":"Lapham","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi250366r42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/can.2023.0056","article-title":"Prevalence and frequency of cannabis use among adults ages 50-80 in the United States.","volume":"9","author":"Fernandez","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"zoi250366r43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1176\/appi.ajp.2021.20081202","article-title":"Prevalence and correlates of cannabis use and cannabis use disorder among U.S. veterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).","volume":"179","author":"Browne","year":"2022","journal-title":"Am J Psychiatry"},{"key":"zoi250366r44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.addbeh.2017.08.010","article-title":"Recent cannabis use among Veterans in the United States: results from a national sample.","volume":"76","author":"Davis","year":"2018","journal-title":"Addict Behav"},{"issue":"6","key":"zoi250366r45","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/10826084.2023.2191700","article-title":"National trends in past-year marijuana use among veterans in the United States, 2013-2019.","volume":"58","author":"Yockey","year":"2023","journal-title":"Subst Use Misuse"},{"issue":"9","key":"zoi250366r46","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/j.pain.0000000000002920","article-title":"Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019.","volume":"164","author":"Mannes","year":"2023","journal-title":"Pain"},{"issue":"4","key":"zoi250366r47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1037\/a0027622","article-title":"Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.","volume":"9","author":"Bonn-Miller","year":"2012","journal-title":"Psychol Serv"},{"key":"zoi250366r48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jpsychires.2021.01.004","article-title":"Comparative associations of problematic alcohol and cannabis use with suicidal behavior in U.S. military veterans: a population-based study.","volume":"135","author":"Hill","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"2","key":"zoi250366r49","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1176\/appi.ajp.20230168","article-title":"Trends in prevalence of cannabis use disorder among U.S. veterans with and without psychiatric disorders between 2005 and 2019.","volume":"181","author":"Livne","year":"2024","journal-title":"Am J Psychiatry"},{"key":"zoi250366r50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-publhealth-032315-021353","article-title":"Using electronic health records for population health research: a review of methods and applications.","volume":"37","author":"Casey","year":"2016","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"zoi250366r51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ajad.12319","article-title":"The epidemiology of substance use disorders in US Veterans: a systematic review and analysis of assessment methods.","volume":"25","author":"Lan","year":"2016","journal-title":"Am J Addict"},{"issue":"5","key":"zoi250366r52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11677","article-title":"Comparison of medical cannabis use reported on a confidential survey vs documented in the electronic health record among primary care patients.","volume":"5","author":"Lapham","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi250366r53","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.18m02350","article-title":"US veterans who do and do not utilize Veterans Affairs health care services: demographic, military, medical, and psychosocial characteristics.","volume":"21","author":"Meffert","year":"2019","journal-title":"Prim Care Companion CNS Disord"},{"key":"zoi250366r54","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106479","article-title":"What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis.","volume":"109","author":"Leung","year":"2020","journal-title":"Addict Behav"},{"issue":"3","key":"zoi250366r55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193706","article-title":"A search algorithm for identifying likely users and non-users of marijuana from the free text of the electronic medical record.","volume":"13","author":"Keyhani","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"zoi250366r56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"8","key":"zoi250366r57","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale.","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"17","key":"zoi250366r58","doi-asserted-by":"publisher","first-page":"9266","DOI":"10.3390\/ijerph18179266","article-title":"Validation of the AUDIT and AUDIT-C for hazardous drinking in community-dwelling older adults.","volume":"18","author":"van Gils","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"zoi250366r59","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0164027504268574","article-title":"A short scale for measuring loneliness in large surveys: results from two population-based studies.","volume":"26","author":"Hughes","year":"2004","journal-title":"Res Aging"},{"key":"zoi250366r60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1745017901006010101","article-title":"PTSD-8: a short PTSD inventory.","volume":"6","author":"Hansen","year":"2010","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"3","key":"zoi250366r61","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.","volume":"46","author":"L\u00f6we","year":"2008","journal-title":"Med Care"},{"issue":"1-3","key":"zoi250366r62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population.","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"issue":"4","key":"zoi250366r63","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MLR.0b013e31827da95a","article-title":"Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration.","volume":"51","author":"Wang","year":"2013","journal-title":"Med Care"},{"issue":"7","key":"zoi250366r64","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1377\/hlthaff.2014.0054","article-title":"Insights from advanced analytics at the Veterans Health Administration.","volume":"33","author":"Fihn","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"18","key":"zoi250366r66","doi-asserted-by":"publisher","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults\u2014United States, 2021.","volume":"72","author":"Cornelius","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi250366r67","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.107049","article-title":"Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: an analysis of states by year, 2008-2017.","volume":"123","author":"Mennis","year":"2021","journal-title":"Addict Behav"},{"issue":"1","key":"zoi250366r68","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54566","article-title":"Tobacco, alcohol, cannabis, and other drug use in the US before and during the early phase of the COVID-19 pandemic.","volume":"6","author":"Compton","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi250366r69","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S2215-0366(22)00161-4","article-title":"Association of cannabis potency with mental ill health and addiction: a systematic review.","volume":"9","author":"Petrilli","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"zoi250366r70","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.drugalcdep.2018.11.012","article-title":"Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.","volume":"195","author":"Arterberry","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"zoi250366r71","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.4841","article-title":"Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial.","volume":"1","author":"Spindle","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi250366r72","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/dar.13800","article-title":"Cannabis vaporisation: understanding products, devices and risks.","volume":"43","author":"MacCallum","year":"2024","journal-title":"Drug Alcohol Rev"},{"issue":"8","key":"zoi250366r73","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/ijerph21080986","article-title":"Associations between cannabis consumption methods and cannabis risk perception.","volume":"21","author":"Choi","year":"2024","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"zoi250366r74","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi250366r75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey.","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp Clin Psychopharmacol"},{"issue":"11","key":"zoi250366r76","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36571","article-title":"Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US.","volume":"4","author":"Jeffers","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11-12","key":"zoi250366r77","doi-asserted-by":"publisher","first-page":"e3591","DOI":"10.1093\/milmed\/usad216","article-title":"Cannabis use among U.S. military veterans following residential substance use disorder treatment.","volume":"188","author":"Mian","year":"2023","journal-title":"Mil Med"},{"issue":"5","key":"zoi250366r78","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archinte.167.5.476","article-title":"Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities.","volume":"167","author":"Seal","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"zoi250366r79","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1186\/s12913-022-08899-y","article-title":"Comparing mental and physical health of U.S. veterans by VA healthcare use: implications for generalizability of research in the VA electronic health records.","volume":"22","author":"Fink","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"zoi250366r80","doi-asserted-by":"publisher","first-page":"853","DOI":"10.15288\/jsad.2018.79.853","article-title":"Substance use disorders among veterans in a nationally representative sample: prevalence and associated functioning and treatment utilization.","volume":"79","author":"Boden","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"issue":"3","key":"zoi250366r81","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17m02118","article-title":"Mental and physical health conditions in US combat veterans: results from the National Health and Resilience in Veterans Study.","volume":"19","author":"Thomas","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"issue":"7","key":"zoi250366r83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States.","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"2","key":"zoi250366r84","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.drugpo.2014.01.003","article-title":"The effects of medical marijuana laws on potency.","volume":"25","author":"Sevigny","year":"2014","journal-title":"Int J Drug Policy"},{"issue":"6","key":"zoi250366r85","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bpsc.2020.12.016","article-title":"A comprehensive review of cannabis potency in the United States in the last decade.","volume":"6","author":"ElSohly","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"zoi250366r86","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev.clinpsy.032408.153621","article-title":"Depression in older adults.","volume":"5","author":"Fiske","year":"2009","journal-title":"Annu Rev Clin Psychol"},{"issue":"8","key":"zoi250366r88","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamainternmed.2019.7335","article-title":"Screening for drug use in primary care: practical implications of the new USPSTF recommendation.","volume":"180","author":"Bradley","year":"2020","journal-title":"JAMA Intern Med"},{"key":"zoi250366r89","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.drugalcdep.2019.04.015","article-title":"Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: an evaluation in three pilot sites.","volume":"201","author":"Richards","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"zoi250366r90","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110946","article-title":"Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.","volume":"251","author":"Matson","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi250366r91","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.14809","article-title":"Cannabis use reported by patients receiving primary care in a large health system.","volume":"7","author":"Gelberg","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi250366r92","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A comprehensive review of the psychometric properties of the Drug Abuse Screening Test.","volume":"32","author":"Yudko","year":"2007","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"zoi250366r93","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.39772","article-title":"Validity of the Single-Item Screen-Cannabis (SIS-C) for cannabis use disorder screening in routine care.","volume":"5","author":"Matson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi250366r94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000515667","article-title":"Motivational interviewing for cannabis use disorders: a systematic review and meta-analysis.","volume":"27","author":"Calomarde-G\u00f3mez","year":"2021","journal-title":"Eur Addict Res"},{"issue":"1","key":"zoi250366r95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/brainsci13010036","article-title":"Contingency management for treatment of cannabis use disorder in co-occurring mental health disorders: a systematic review.","volume":"13","author":"Rodas","year":"2022","journal-title":"Brain Sci"},{"issue":"1","key":"zoi250366r96","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and cannabis use disorder.","volume":"7","author":"Connor","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"zoi250366r97","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/jcm8111819","article-title":"Medical cannabis for older patients-treatment protocol and initial results.","volume":"8","author":"Abuhasira","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"zoi250366r98","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/jgs.18180","article-title":"Trends in emergency department visits associated with cannabis use among older adults in California, 2005-2019.","volume":"71","author":"Han","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"zoi250366r99","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials.","volume":"162","author":"Fisher","year":"2021","journal-title":"Pain"},{"issue":"2","key":"zoi250366r100","first-page":"e78","article-title":"Systematic review of systematic reviews for medical cannabinoids: pain, nausea and vomiting, spasticity, and harms.","volume":"64","author":"Allan","year":"2018","journal-title":"Can Fam Physician"},{"key":"zoi250366r101","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106635","article-title":"Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: systematic review and meta-analysis.","volume":"102","author":"de Carvalho Reis","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"40","key":"zoi250366r102","doi-asserted-by":"publisher","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife.","volume":"109","author":"Meier","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"zoi250366r103","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjcard.2006.03.024","article-title":"Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study).","volume":"98","author":"Rodondi","year":"2006","journal-title":"Am J Cardiol"},{"issue":"2","key":"zoi250366r104","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1086\/297751","article-title":"Asking sensitive questions: the impact of data collection mode, question format, and question context.","volume":"60","author":"Tourangeau","year":"1996","journal-title":"Public Opin Q"},{"issue":"4","key":"zoi250366r105","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3758\/s13428-014-0533-4","article-title":"Disclosure of sensitive behaviors across self-administered survey modes: a meta-analysis.","volume":"47","author":"Gnambs","year":"2015","journal-title":"Behav Res Methods"},{"key":"zoi250366r2","unstructured":"SAMHSA. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. 2014. Accessed March 26, 2025. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUHresultsPDFWHTML2013\/Web\/NSDUHresults2013.pdf"},{"key":"zoi250366r3","unstructured":"SAMHSA. Results from the 2023 National Survey on Drug Use and Health: detailed tables. HHS Publication No. PEP24-07-021-006, NSDUH Series H-59. 2024. Accessed October 16, 2024. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt47095\/National%20Report\/National%20Report\/2023-nsduh-annual-national.pdf"},{"key":"zoi250366r5","unstructured":"SAMHSA. Behavioral health among older adults: results from the 2021 and 2022 National Surveys on Drug Use and Health. SAMHSA Publication No. PEP24-07-018. 2024. Accessed May 23, 2024. https:\/\/www.samhsa.gov\/data\/report\/older-adult-behavioral-health-report-2021-2022"},{"key":"zoi250366r9","unstructured":"SAMHSA. Key substance use and mental health indicators in the united states: results from the 2022 National Survey on Drug Use and Health. Table 1.7B. Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022. Accessed March 26, 2025. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42728\/NSDUHDetailedTabs2022\/NSDUHDetailedTabs2022\/NSDUHDetTabsSect1pe2022.htm"},{"key":"zoi250366r21","unstructured":"Edemekong? PF, Bomgaars? DL, Sukumaran? S, . Activities of daily living. In: StatPearls [Internet]. Updated June 26, 2023. Accessed March 26, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470404\/"},{"key":"zoi250366r65","unstructured":"Wallace? M, Shelkey? M. Katz Index of Independence in Activities of Daily Living (ADL). The Hartford Institute for Geriatric Nursing; 2007. Accessed May 22, 2024. https:\/\/www.alz.org\/careplanning\/downloads\/katz-adl.pdf"},{"key":"zoi250366r82","unstructured":"VA\/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder 2023. Accessed March 26, 2025. https:\/\/www.healthquality.va.gov\/guidelines\/mh\/ptsd\/"},{"key":"zoi250366r87","unstructured":"US Preventive Services Task Force. Unhealthy drug use: screening. Accessed October, 21, 2024. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/drug-use-illicit-screening"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2833976\/pravosud_2025_oi_250366_1746646893.29961.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:01:06Z","timestamp":1747220466000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2833976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.10173","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]}}}